Imidin N 1 (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride acts as a selective alpha‑adrenergic agonist. It binds to alpha‑receptors on nasal blood vessels, causing vasoconstriction, which limits blood flow and fluid leakage, thereby decreasing mucosal edema and opening the nasal airway.

The appropriate dose of Imidin N 1 is determined by a qualified healthcare professional based on the patient’s age, condition and response. Users should follow the prescriber’s instructions and the product label.

Safety data for xylometazoline hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Imidin N 1.

To order Imidin N 1, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imidin N 1 (xylometazoline) is an imidazoline‑type decongestant that provides rapid vasoconstriction with a typical onset of action within minutes. Compared with phenylephrine‑based sprays, xylometazoline often offers a longer duration of relief but shares similar cautions regarding rebound congestion with prolonged use.

Imidin N 1 should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and extreme heat to maintain its stability and efficacy.

Imidin N 1 is applied intranasally as a spray. The patient should gently blow the nose, insert the nozzle into each nostril, and spray the recommended number of sprays as directed by the prescriber, typically one to two sprays per nostril.

Serious risks include severe hypertension, tachycardia, rebound nasal congestion after prolonged use, and rare allergic reactions such as rash, angioedema or nasal ulceration. Users should discontinue the product and seek medical attention if these events occur.

Individuals with known hypersensitivity to xylometazoline or other imidazoline derivatives, patients with uncontrolled hypertension, severe cardiovascular disease, or those who have experienced rebound congestion from prior nasal decongestant use should avoid Imidin N 1 unless advised otherwise by a healthcare professional.